Usefulness of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in the elderly

被引:0
|
作者
Guillaumou, G. [1 ]
Celton, B. [1 ]
Ferreira, E. [1 ]
Ventura, E. [2 ]
Reygrobellet, P. [1 ]
Durant, R. [1 ]
机构
[1] CHU Montpellier, Ctr Antonin Balmes, F-34295 Montpellier 5, France
[2] CHU Montpellier, Hop Lapeyronie, Serv Biochem, F-34295 Montpellier 5, France
来源
REVUE DE MEDECINE INTERNE | 2009年 / 30卷 / 08期
关键词
Elderly; Natriuretic peptide; BNP; NT-proBNP; Geriatry; CONGESTIVE-HEART-FAILURE; TISSUE DOPPLER-ECHOCARDIOGRAPHY; VENTRICULAR SYSTOLIC FUNCTION; CORONARY-ARTERY-DISEASE; IN-HOSPITAL MORTALITY; PATIENTS AGED 65; ACUTE DYSPNEA; EMERGENCY DIAGNOSIS; PROGNOSTIC VALUE; RENAL-FUNCTION;
D O I
10.1016/j.revmed.2008.11.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide are biomarkers secreted both in response to myocardial stretch and increased ventricular wall stress. They are now largely used in cardiovascular disease in adults, especially as diagnostic and prognostic tools. This article aims at synthesizing existing data concerning the usefulness of natriuretic peptides in elderly patients. With aging, co-morbidities such as renal failure are common and lead to an increase in circulating concentrations of natriuretic peptides. Nevertheless, their usefulness is relevant in geriatric practice. Their role has been well established in heart failure, not only in diagnosis, using two thresholds to decrease misclassification, but also in prognosis. In the future, natriuretic peptides could be used as prognosis tools in acute coronary syndrome, in cardiovascular risk assessment or in management of heart valve disease. However, further investigations in elderly people are needed before validating these indications in routine geriatric practice. (C) 2008 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:678 / 685
页数:8
相关论文
共 50 条
  • [1] Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals
    Soldin, SJ
    Soldin, OP
    Boyajian, AJ
    Taskier, MS
    [J]. CLINICA CHIMICA ACTA, 2006, 366 (1-2) : 304 - 308
  • [2] N-terminal pro-brain natriuretic peptide in the elderly with myocardial infarction
    Szadkowska, Iwona
    Goch, Jan Henryk
    Kawinski, Janusz
    Chizynski, Krzysztof
    [J]. CLINICAL CARDIOLOGY, 2008, 31 (09) : 443 - 447
  • [3] Equivalence Between Point-of-Care N-terminal Pro-Brain Natriuretic Peptide and Laboratory N-terminal Pro-Brain Natriuretic Peptide?
    Wiwanitkit, Viroj
    [J]. POINT OF CARE, 2011, 10 (01): : 34 - 34
  • [4] Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea
    Alibay, Y
    Beauchet, A
    El Mahmoud, R
    Schmitt, C
    Brun-Ney, D
    Benoit, MO
    Dubourg, O
    Boileau, C
    Jondeau, G
    Puy, H
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2005, 59 (1-2) : 20 - 24
  • [5] N-Terminal Pro-Brain Natriuretic Peptide Trial Design
    Hersh, Andrew
    Aberegg, Scott K.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 196 (04) : 530 - 530
  • [6] N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE AND METABOLIC SYNDROME
    Lin, J. -W.
    Chiu, F. -C.
    Hwang, J. -J.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 41 - 41
  • [7] Clinical significance of N-terminal pro-brain natriuretic peptide
    张向阳
    朱继红
    [J]. 中华医学杂志(英文版), 2004, (11) : 116 - 122
  • [8] N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE LEVEL IN SSc
    Pinto, S.
    Videira, T.
    Ferreira, P.
    [J]. RHEUMATOLOGY, 2012, 51 : 116 - 117
  • [9] Myocardial Infarction and N-Terminal Pro-Brain Natriuretic Peptide
    Arjamaa, Olli
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (09): : 1697 - 1697
  • [10] Clinical significance of N-terminal pro-brain natriuretic peptide
    张向阳
    朱继红
    [J]. Chinese Medical Journal, 2004, (11)